SFB 1112 Publication Highlight: Schulz et al., PNAS: Data-based modeling of drug penetration ...

News vom 21.03.2017

Schulz R
, Yamamoto K, Klossek A, Flesch R, Hönzke S, Rancan F, Vogt A, Blume-Peytavi U, Hedtrich S, Schäfer-Korting M, Rühl E, Netz RR:

Data-based modeling of drug penetration profiles explains human skin barrier function by the interplay of diffusivity and free energy profiles.

Proceedings of the National Academy of Sciences of the United States of America
Proc Nat Acad Sci (PNAS) 2017, DOI 10.1073/pnas.1620636114
(epublication ahead of print)


Based on experimental concentration depth profiles of the antiinflammatory drug dexamethasone in human skin, we model the time-dependent drug penetration by the 1D general diffusion equation that accounts for spatial variations in the diffusivity and free energy. For this, we numerically invert the diffusion equation and thereby obtain the diffusivity and the free-energy profiles of the drug as a function of skin depth without further model assumptions. As the only input, drug concentration profiles derived from X-ray microscopy at three consecutive times are used. For dexamethasone, skin barrier function is shown to rely on the combination of a substantially reduced drug diffusivity in the stratum corneum (the outermost epidermal layer), dominant at short times, and a pronounced free-energy barrier at the transition from the epidermis to the dermis underneath, which determines the drug distribution in the long-time limit. Our modeling approach, which is generally applicable to all kinds of barriers and diffusors, allows us to disentangle diffusivity from free-energetic effects. Thereby we can predict short-time drug penetration, where experimental measurements are not feasible, as well as long-time permeation, where ex vivo samples deteriorate, and thus span the entire timescales of biological barrier functioning.


Human skin consists of distinct layers and is designed to prevent water loss and to keep harmful materials out, which makes transcutaneous drug delivery challenging. A model for drug diffusion within skin is introduced that as the only input requires experimental concentration profiles measured at three distinct penetration times. For the specific example of the antiinflammatory drug dexamethasone, the modeling shows that both free-energy and diffusivity profiles are highly inhomogeneous, which reveals the basic mechanism of epidermal barrier function: slow diffusion in the outer stratum corneum hinders fast penetration into the skin, whereas a pronounced free-energy step from the epidermis to the dermis underneath reduces long-time permeation. Targeted drug delivery strategies through skin must reflect these properties.

 http://www.pnas.org/content/early/2017/03/16/1620636114.full  (21.03.2017)

7 / 34